Abbott Laboratories ABT
NYSE ABT
$107.25 -2.04 (-1.87%)
At close: Nov 12, 2026 · 4:02 PM EST

Abbott Laboratories (ABT) Asset Writedowns and Impairment (2009 - 2012)

Updated

Abbott Laboratories (ABT) reported Asset Writedowns and Impairment of $947 million for FY2016.

Analysis

Abbott Laboratories (ABT) Asset Writedowns and Impairment (2009 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn
3 Danaher 161.92 Bn 141.57 Bn 3.84 Bn
4 Intuitive Surgical 155.43 Bn 135.72 Bn 2.08 Bn
5 Medtronic 131.93 Bn 97.45 Bn 6.34 Bn
6 Stryker 119.74 Bn 105.93 Bn 4.25 Bn
7 Boston Scientific 64.30 Bn 59.73 Bn 3.43 Bn
8 Edwards Lifesciences 61.65 Bn 44.86 Bn 1.35 Bn
9 Agilent Technologies 48.79 Bn 41.68 Bn 1.04 Bn
10 GE HealthCare Technologies 37.34 Bn 25.57 Bn 2.22 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 211.00 Mn
Dec 31, 2011 212.00 Mn
Dec 31, 2010 293.00 Mn
Dec 31, 2009 251.00 Mn
API Access

Abbott Laboratories Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ABT&period=max&api_key=YOUR_API_KEY